Management of COVID-19 in Kidney Transplant Recipients: A Single-Center Case Series

Table 1

Baseline characteristics of KTRs with COVID-19.

Patient	Gender	Age (years)	Comorbidities	Time from transplant (years)	IST regimen
1	Male	66	Obesity, DM	4	Tacrolimus, MMF/MPA, steroid
2	Female	31	None	5	Tacrolimus, MMF/MPA, steroid
3	Male	51	DM, hypertension, CAD	3	Tacrolimus, MMF/MPA, steroid
4	Male	58	DM, hypertension, CAD	0.8	Tacrolimus, MMF/MPA, steroid
5	Male	34	None	4	Tacrolimus, MMF/MPA, steroid
6	Female	31	Hypertension	1	Tacrolimus, MMF/MPA, steroid
7	Male	55	DM, hypertension,	3	Tacrolimus, MMF/MPA, steroid
8	Male	30	Hypertension	4	Tacrolimus, MMF/MPA, steroid
9	Female	42	Obesity	8	Tacrolimus, azathioprine, steroid
10	Male	48	Hypertension	2	Tacrolimus, MMF/MPA, steroid
11	Male	58	Hypertension, CAD	4	Tacrolimus, MMF/MPA, steroid
12	Female	33	None	5	Tacrolimus, azathioprine, steroid
13	Male	51	DM, hypertension, CAD, bradycardia with permanent pacemaker, pulmonary tuberculosis, COPD	2	Tacrolimus, MMF/MPA, steroid
14	Male	36	None	5	Tacrolimus, everolimus
15	Male	55	Obesity, hyperuricemia	6	Tacrolimus, MMF/MPA
16	Male	60	Hypertension	6	Tacrolimus, MMF/MPA
17	Male	46	Obesity	6	Tacrolimus, MMF/MPA
18	Female	56	Obesity, DM	5	Tacrolimus, MMF/MPA
19	Male	52	DM, hypertension	3	Tacrolimus, MMF/MPA

CAD: coronary artery disease; DM: diabetes mellitus; IST: immunosuppressive therapy.